IRIS
RIVARA, Mirko
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.583
AS - Asia 2.304
EU - Europa 1.954
SA - Sud America 252
AF - Africa 135
Continente sconosciuto - Info sul continente non disponibili 74
OC - Oceania 1
Totale 7.303
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.492
SG - Singapore 759
CN - Cina 705
IT - Italia 459
VN - Vietnam 347
FI - Finlandia 297
SE - Svezia 247
IE - Irlanda 232
DE - Germania 196
BR - Brasile 192
HK - Hong Kong 187
UA - Ucraina 142
NL - Olanda 86
BD - Bangladesh 81
GB - Regno Unito 76
ZA - Sudafrica 73
FR - Francia 71
RU - Federazione Russa 62
CA - Canada 56
TR - Turchia 42
IN - India 38
CI - Costa d'Avorio 25
KR - Corea 22
JP - Giappone 19
PH - Filippine 19
AR - Argentina 18
MX - Messico 17
CZ - Repubblica Ceca 16
IQ - Iraq 16
BE - Belgio 15
PL - Polonia 12
EC - Ecuador 11
TH - Thailandia 11
PK - Pakistan 10
CO - Colombia 9
ES - Italia 9
EG - Egitto 8
ID - Indonesia 8
CL - Cile 7
LT - Lituania 7
MA - Marocco 7
PT - Portogallo 7
TN - Tunisia 7
VE - Venezuela 7
AT - Austria 6
CR - Costa Rica 6
JO - Giordania 6
TW - Taiwan 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
ET - Etiopia 3
IR - Iran 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
AM - Armenia 2
BB - Barbados 2
KE - Kenya 2
KW - Kuwait 2
LY - Libia 2
NI - Nicaragua 2
PE - Perù 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
BF - Burkina Faso 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KN - Saint Kitts e Nevis 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
Totale 7.229
Salva come PNG Salva come JPEG
Città #
Singapore 397
Ashburn 301
San Jose 251
Dublin 232
Chandler 226
Beijing 176
Hong Kong 176
Jacksonville 154
Santa Clara 152
Dallas 115
Ann Arbor 97
Ho Chi Minh City 97
Council Bluffs 96
Parma 96
Boardman 93
Hanoi 86
Johannesburg 71
Munich 71
New York 70
Hefei 69
Dearborn 67
Nanjing 62
Los Angeles 58
Milan 53
Shanghai 51
Lauterbourg 45
Princeton 45
Chicago 35
Helsinki 34
Wilmington 32
Izmir 31
San Mateo 29
Toronto 29
Moscow 26
Abidjan 25
Frankfurt am Main 25
Buffalo 24
Turku 24
London 20
Seoul 19
Shenyang 18
Guangzhou 17
Nanchang 17
Seattle 17
Tokyo 17
Columbus 16
Da Nang 16
Haiphong 16
Jinan 16
Kunming 16
São Paulo 16
Modena 15
Bremen 14
Brussels 14
Des Moines 14
Hebei 14
The Dalles 13
Jiaxing 11
Bologna 10
Brno 10
Brooklyn 10
Chennai 10
Reggio Emilia 10
Woodbridge 10
Warsaw 9
Amsterdam 8
Changsha 8
Montreal 8
Nuremberg 8
Tianjin 8
Baghdad 7
Bengaluru 7
Rome 7
Ankara 6
Atlanta 6
Belo Horizonte 6
Chengdu 6
Genoa 6
Houston 6
Jakarta 6
Mexico City 6
Ottawa 6
Piacenza 6
Stockholm 6
Vienna 6
Amman 5
Auburn Hills 5
Falls Church 5
Hangzhou 5
Manchester 5
Norwalk 5
Phoenix 5
Quito 5
Redondo Beach 5
Thái Bình 5
Tunis 5
Abbiategrasso 4
Ancona 4
Brescia 4
Bắc Ninh 4
Totale 4.310
Salva come PNG Salva come JPEG
Nome #
Chemico-Physical Properties of Some 1,1′-Bis-alkyl-2,2′-hexane-1,6-diyl-bispyridinium Chlorides Hydrogenated and Partially Fluorinated for Gene Delivery 225
NEW ALKBH2 AND ALKBH5 INHIBITORS FOR TREATING GLIOBLASTOMA 218
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 206
Gene-Delivery Ability of New Hydrogenated and Partially Fluorinated Gemini bispyridinium Surfactants with Six Methylene Spacers 203
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 201
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 199
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 185
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 182
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 181
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 165
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 165
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 161
Chiral NMR discrimination of the diastereoisomeric salts of the H(3)-antagonist 2-[3-(1H-imidazol-4-ylmethyl)piperidin-1-yl]-1H-benzimidazole. 160
A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4-Methylhistamine 159
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 157
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 154
Antioxidant and cytoprotective activity of indole derivatives related to melatonin 154
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H(3) antagonist ROS203 in rat plasma. 154
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 153
2,4(5)-Diarylimidazoles: Synthesis and Biological Evaluation of a New Class of Sodium Channel Blockers against hNav1.2 152
2,4(5)-Diarylimidazoles as Inhibitors of hNaV1.2 Sodium Channels: Pharmacological Evaluationand Structure-Property Relationships 151
Advances in Design and Development of Sodium Channel Blockers. 150
Anticonvulsant Activity of 2,4(1H)-Diarylimidazoles in Mice and Rats Acute Seizure Models 144
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 144
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 143
Anticonvulsant Activity of 2,4(5)-Diarylimidazoles in Mice and Rat Models 143
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 143
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 143
Biological evaluation of imidazobenzoxazines, imidazobenzoxazin-5-ones and imidazobenzoxazin-5-thiones as sodium channel blockers 141
Novel Sodium Channel Antagonists in the Treatment of Neuropathic Pain 137
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 134
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 130
Drug repurposing approaches to fight Dengue virus infection and related diseases 129
Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity 122
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 120
In vivo Screening of Diarylimidazoles as Anticonvulsant Agents 120
IMIDAZOBENZOXAZIN-5-THIONE (MV1035) TO OVERCOME THE BLOOD-BRAIN BARRIER AND TARGET CNS DISEASES 118
Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry 118
NMR Analysis of a Series of Imidazobenzoxazines 117
A Practical Synthesis of 2,4(5)-Diarylimidazoles from Simple Building Blocks 117
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 110
Sodium Channel Blocking Activity and In-vivo Testing of New Phenyl-imidazole Derivatives. 110
Microwave Assisted Efficient Synthesis of Imidazole-based Privileged Structure 109
Sodium channel blockers for neuropathic pain. 108
Recent Advances in the Medicinal Chemistry of Sodium Channel Blockers and their Therapeutic Potential 105
Sodium channel blockers: a patent review (2010 - 2014) 104
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 99
Sodium Channel Blockers as Therapeutic Target for Treating Epilepsy: Recent Updates 99
NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet syndrome 93
Recent advances in the discovery of ALKBH 1–8 inhibitors. 75
Subtype-selective small molecule inhibitors reveal a fundamental role for Nav1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release 72
Design and Biological Evaluation of ALKBH2 and ALKBH5 Inhibitors as Adjuvants to Temozolomide-based Glioblastoma Treatment. 12
From Sodium Channels Blockers to Dual ALKBH2/ALKBH5 Inhibitors: a Novel Therapeutic Strategy for Glioblastoma Treatment. 9
Totale 7.303
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.369
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.369
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022226 0 2 5 18 14 7 29 26 21 17 17 70
2022/2023929 106 108 68 57 71 118 17 44 275 12 36 17
2023/2024411 22 32 11 14 43 84 38 29 19 21 35 63
2024/20251.277 64 78 99 90 72 137 41 77 101 114 128 276
2025/20262.907 251 291 359 305 396 171 305 90 328 216 104 91
2026/2027193 83 110 0 0 0 0 0 0 0 0 0 0
Totale 7.303